These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 15323313

  • 1. [Transdermal contraception--a new beginning].
    Sigridov I, Dikov I, Ivanov S.
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():19-27. PubMed ID: 15323313
    [No Abstract] [Full Text] [Related]

  • 2. [Hormonal contraceptive patch].
    Lidegaard O.
    Ugeskr Laeger; 2004 Oct 04; 166(41):3591. PubMed ID: 15515462
    [No Abstract] [Full Text] [Related]

  • 3. The transdermal contraceptive patch: a new approach to hormonal contraception.
    Burkman RT.
    Int J Fertil Womens Med; 2002 Oct 04; 47(2):69-76. PubMed ID: 11991433
    [Abstract] [Full Text] [Related]

  • 4. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR, Loomba PK.
    J Reprod Med; 2003 Jul 04; 48(7):525-40. PubMed ID: 12953327
    [Abstract] [Full Text] [Related]

  • 5. Transdermal contraception.
    Creasy GW, Abrams LS, Fisher AC.
    Semin Reprod Med; 2001 Dec 04; 19(4):373-80. PubMed ID: 11727179
    [Abstract] [Full Text] [Related]

  • 6. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.
    Goa KL, Warner GT, Easthope SE.
    Treat Endocrinol; 2003 Dec 04; 2(3):191-206. PubMed ID: 15966567
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
    Devineni D, Skee D, Vaccaro N, Massarella J, Janssens L, LaGuardia KD, Leung AT.
    J Clin Pharmacol; 2007 Apr 04; 47(4):497-509. PubMed ID: 17389559
    [Abstract] [Full Text] [Related]

  • 8. [A transdermal form of combined hormonal contraceptives (EVRA)].
    Fanta M.
    Ceska Gynekol; 2003 Oct 04; 68(5):341-5. PubMed ID: 14692356
    [Abstract] [Full Text] [Related]

  • 9. Progress in contraception: new technology.
    Linn ES.
    Int J Fertil Womens Med; 2003 Oct 04; 48(4):182-91. PubMed ID: 13677551
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra).
    Zieman M.
    Fertil Steril; 2002 Feb 04; 77(2 Suppl 2):S1-2. PubMed ID: 11849629
    [No Abstract] [Full Text] [Related]

  • 12. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
    Levine JP.
    J Fam Pract; 2004 Nov 04; 53(11):904-13. PubMed ID: 15527729
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra).
    Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit.
    J Fam Plann Reprod Health Care; 2004 Jan 04; 30(1):43-5. PubMed ID: 15006313
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic overview of Ortho Evra/Evra.
    Abrams LS, Skee D, Natarajan J, Wong FA.
    Fertil Steril; 2002 Feb 04; 77(2 Suppl 2):S3-12. PubMed ID: 11849630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.